Clinical trials: Panic Disorder (With or Without Agoraphobia)
- Condition Panic Disorder (With or Without Agoraphobia)
- Funder type Industry (pharma, biotech, devices)
Healthy Subjects
An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing Sites
Study to evaluate if Xanax sustained release tablets manufactured at two different sites provide similar drug levels in the blood.
- Trial name
- NCT01330472
- Testing
- Xanax XR tablets 3 mg (sourced from Caugus), Xanax XR tablets 3 mg (sourced from Barceloneta)
- Where
- Singapore
- Volunteers
- 16 people, healthy volunteers welcome
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.